Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
17.82
+0.64 (3.76%)
Oct 5, 2026, 1:34 PM EDT - Market open
Attovia Therapeutics Revenue
Attovia Therapeutics had revenue of $450.00K in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $1.80M. In the year 2025, Attovia Therapeutics had annual revenue of $1.35M.
Revenue (ttm)
$1.80M
Revenue Growth
n/a
P/S Ratio
451.44
Revenue / Employee
$40,909
Employees
44
Market Cap
813.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.35M | - | - |
| Dec 31, 2024 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
ATTO News
- 6 days ago - Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026 - GlobeNewsWire
- 19 days ago - Attovia Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 weeks ago - Attovia Therapeutics Slides: Corporate presentation - Filings
- 4 weeks ago - Attovia Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Attovia reports Q2 EPS ($4.88), consensus ($4.61) - TheFly
- 4 weeks ago - Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 4 weeks ago - Attovia Therapeutics Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Attovia Therapeutics Earnings release: Q2 2026 - Filings